Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?
The newly observed nongenomic effects of glucocorticoids on signaling pathways operating in neutrophils in vitro will stimulate further investigations on pathogenic mechanisms and drug actions in bullous skin diseases.